The Scientist

» cancer, culture and developmental biology

Most Recent

image: The Two Faces of Fish Oil

The Two Faces of Fish Oil

By | April 1, 2016

The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

3 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

In recent years, research has demonstrated that microbes living in and on the mammalian body can affect cancer risk, as well as responses to cancer treatment.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By | April 1, 2016

How cancer cells fuel their rapid growth

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: The Forces of Cancer

The Forces of Cancer

By | April 1, 2016

A tumor’s physical environment fuels its growth and causes treatment resistance.

0 Comments

image: Under Pressure

Under Pressure

By | April 1, 2016

The causes and consequences of physical forces in the tumor microenvironment

0 Comments

image: Cancer Be Damned

Cancer Be Damned

By | April 1, 2016

Teenager Lauren Bendesky turned her cancer diagnosis on its head, using herself as a research subject to test potential therapies.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech